SCHEMBL7844718

SCHEMBL7844718

COC(=O)N(C)C(=O)c1cccc2c1CC(Br)C2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.36
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
KEAP1 Q14145 1/20 0.33
PTPRC P08575 1/20 0.32
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
GAA P10253 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
HPGD P15428 1/20 0.30
ALOX15 P16050 1/20 0.30
CYP2C19 P33261 1/20 0.30
HSD17B10 Q99714 1/20 0.30
METAP1 P53582 1/20 0.30
CYP19A1 P11511 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7842879 0.78 ALDH1A1 (0.41) KDM4EMAPTLMNAPOLBKEAP1
SCHEMBL7844715 0.74 ALDH1A1 (0.38) ACHEKDM4EPOLBKEAP1PTPRC
SCHEMBL7846415 0.73 GAA (0.31) GAASMN1; SMN2
SCHEMBL7846412 0.71 JAK3 (0.34) KDM4EALDH1A1GAAMEN1KMT2A
SCHEMBL8099246 0.69 ACHE (0.45) ACHEKDM4EMAPTLMNAPOLB
SCHEMBL8314704 0.68 NPC1 (0.51) KDM4EMAPTLMNAPOLBALDH1A1
SCHEMBL7843220 0.68 CHRNB2 (0.53) KDM4ELMNAALDH1A1GAAHPGD
SCHEMBL8560121 0.67 ACHE (0.66) ACHEPOLBALDH1A1METAP1CYP19A1
SCHEMBL8555103 0.65 PIM1 (0.46) ACHEKDM4EALDH1A1GAAMETAP1
SCHEMBL7847650 0.65 ACHE (0.34) ACHEKDM4EMAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820455-B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES AVENTIS PHARMA SA (FR) 2001-10-31 EP disclosed
US-6057454-A USEFUL FOR TREATING OR PREVENTING ALL ISCHAEMIAS (SUCH AS FOCAL OR GLOBAL ISCHAEMIA) RESULTING FROM CEREBROVASCULAR DISORDERS RHONE-POULENC RORER S.A. (FR) 2000-05-02 US disclosed
US-5902803-A 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives RHONE-POULENC RORER S.A. (FR) 1999-05-11 US disclosed
EP-0820455-A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES Aventis Pharma S.A. (FR) 1998-01-28 EP disclosed
WO-1996031511-A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES RHONE-POULENC RORER S.A. (FR) 1996-10-10 WO disclosed